SecBot SecBot
SECBOTREPLAY Home › Report › CVS

CVS · Q3 Adj. EPS $2.09, guide raised

CVS HEALTH Corp · 8-K filed Nov 4, 2026 at 06:31 ET

At the news

BULLISHIMPACT 6/10

8-K filed Nov 4, 2026 at 06:31 ET

CVS Health reported Q3 2026 revenue of $108.4B (+5.4% YoY) and Adjusted EPS of $2.09, above the consensus estimate of $1.65. The company raised full-year 2026 guidance: GAAP diluted EPS to at least $6.98 (from $6.84-$7.04), Adjusted EPS to at least $8.20 (from $7.90-$8.10), and cash flow from operations to at least $15.5B (from at least $11.5B). The Health Care Benefits segment continued its margin recovery, with MBR improving 150 bps YoY to 91.3%.

  • Q3 2026 total revenues of $108.4B, up 5.4% YoY from $102.9B
  • Q3 2026 GAAP diluted EPS of $1.68 vs a loss of $3.13 in the prior year
  • Q3 2026 Adjusted EPS of $2.09, up from $1.60 YoY
  • Full-year 2026 GAAP diluted EPS guidance raised to at least $6.98 from $6.84-$7.04

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access